Bristol Myers Analysts Recommendations and Consensus

<div class='circular--portrait' style='background:#754DEB;color: white;font-size:3em;padding-top: 35px;;'>BMY</div>
BMY -- USA Stock  

Earning Report: February 6, 2020  

The current analyst and expert consensus on Bristol Myers is Buy with 4 hold recommendations. The current projected target price consensus is 65.78 with 9 analysts opinions. One of the most common ways Bristol Myers Squibb analysists use to provide buy or sell recommendation to public are conference calls analysis and financial statements evaluations. Some experts can also talk to Bristol Myers vendors, executives, and/or customers. Bristol Myers recommendation module provides expert sentiment on the projected Bristol Myers Squibb target price to derive its highest and lowest estimates based on target price standard deviation of 7.854. Continue to Macroaxis Advice on Bristol Myers to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.

Bristol Myers Target Price Consensus

Number of Opinions12
Lowered Outlook0
Raized Outlook0
Buy
Macroaxis Recommendation   Exposure   Valuation

Bristol Myers Target Price Projection

Current Price

Bristol Myers Market Quote

Low Price64.93Odds
High Price66.16Odds

64.93

Target Price

Analyst Consensus On Target Price

Low Estimate53.0Odds
High Estimate75.0Odds
Number of Analysts9
Standard Deviation7.854

65.777

Bristol Myers Analysit Ratings

Average Consensus